ArticleBioinformation2025
Retrospective study on MRI accuracy in assessing liver fibrosis among patients with chronic liver disease.
Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Magnetic resonance imaging (MRI) is increasingly being utilized for the non-invasive liver fibrosis evaluation among chronic liver disease (CLD) patients. Therefore, it is of interest to assess the staging and diagnostic accuracy of MRI for liver fibrosis compared to histopathological outcome in 150 patients with CLD. MRI data were analyzed with advanced techniques such as elastography and T1/T2 mapping and these results were matched against fibrosis stages ascertained through biopsy. The sensitivity and specificity of MRI in detecting extensive fibrosis ≥F2 were 88% and 91%, respectively. Fibrosis scores determined by MRI were correlated with histopathological stage with r = 0.87, p < 0.01. The findings revealed MRI as an effective non-invasive modality for liver fibrosis that, complementarily, decreases the position of invasive biopsy in patients with CLD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.